Pmv Pharmaceuticalsinc Stock Cash And Equivalents
| PMVP Stock | USD 2.10 0.05 2.33% |
Pmv PharmaceuticalsInc fundamentals help investors to digest information that contributes to Pmv PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Pmv Stock. The fundamental analysis module provides a way to measure Pmv PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pmv PharmaceuticalsI stock.
Pmv | Cash And Equivalents |
Pmv PharmaceuticalsInc Company Cash And Equivalents Analysis
Pmv PharmaceuticalsI's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Pmv PharmaceuticalsI Cash And Equivalents | 277.43 M |
Most of Pmv PharmaceuticalsI's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pmv PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pmv Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for Pmv PharmaceuticalsI is extremely important. It helps to project a fair market value of Pmv Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since Pmv PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pmv PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pmv PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
Pmv Cash And Cash Equivalents Changes
Cash And Cash Equivalents Changes |
|
In accordance with the recently published financial statements, Pmv PharmaceuticalsInc has 277.43 M in Cash And Equivalents. This is 66.2% lower than that of the Biotechnology sector and 37.95% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 89.73% higher than that of the company.
Pmv Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pmv PharmaceuticalsI's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pmv PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Pmv PharmaceuticalsI by comparing valuation metrics of similar companies.Pmv PharmaceuticalsI is currently under evaluation in cash and equivalents category among related companies.
Pmv PharmaceuticalsI Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pmv PharmaceuticalsI from analyzing Pmv PharmaceuticalsI's financial statements. These drivers represent accounts that assess Pmv PharmaceuticalsI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pmv PharmaceuticalsI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.6B | 2.8B | 1.0B | 396.7M | 148.8M | 141.4M | |
| Enterprise Value | 1.7B | 2.4B | 881.4M | 302.4M | 123.6M | 117.4M |
Pmv PharmaceuticalsI ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pmv PharmaceuticalsI's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pmv PharmaceuticalsI's managers, analysts, and investors.Environmental | Governance | Social |
Pmv Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | (76.89 M) | ||||
| Shares Outstanding | 51.44 M | ||||
| Shares Owned By Insiders | 2.60 % | ||||
| Shares Owned By Institutions | 92.21 % | ||||
| Number Of Shares Shorted | 2.82 M | ||||
| Price To Book | 0.41 X | ||||
| EBITDA | (78.88 M) | ||||
| Net Income | (68.96 M) | ||||
| Cash And Equivalents | 277.43 M | ||||
| Cash Per Share | 6.08 X | ||||
| Total Debt | 13.29 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 24.76 X | ||||
| Book Value Per Share | 4.13 X | ||||
| Cash Flow From Operations | (55.66 M) | ||||
| Short Ratio | 6.22 X | ||||
| Earnings Per Share | (1.32) X | ||||
| Price To Earnings To Growth | (0.31) X | ||||
| Target Price | 8.2 | ||||
| Number Of Employees | 63 | ||||
| Beta | 1.55 | ||||
| Market Capitalization | 108.03 M | ||||
| Total Asset | 252.15 M | ||||
| Retained Earnings | (310 M) | ||||
| Working Capital | 193.38 M | ||||
| Net Asset | 252.15 M |
About Pmv PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Pmv PharmaceuticalsI Piotroski F Score and Pmv PharmaceuticalsI Altman Z Score analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.